Single-Center Comparison of [<sup>64</sup>Cu]-DOTAGA-PSMA and [<sup>18</sup>F]-PSMA PET–CT for Imaging Prostate Cancer
Introduction: the diagnostic performance of [<sup>64</sup>Cu]-DOTAGA-PSMA PET–CT imaging was compared retrospectively to [<sup>18</sup>F]-PSMA PET–CT in prostate cancer patients with recurrent disease and in the primary staging of selected patients with advanced local and pos...
Main Authors: | Siroos Mirzaei, Rainer Lipp, Shahin Zandieh, Asha Leisser |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/28/5/353 |
Similar Items
-
[<sup>68</sup>Ga]Ga-PSMA-11: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
by: Ute Hennrich, et al.
Published: (2021-07-01) -
Diagnostic Performance of [<sup>18</sup>F]Fluorocholine and [<sup>68</sup>Ga]Ga-PSMA PET/CT in Prostate Cancer: A Comparative Study
by: Zeinab Paymani, et al.
Published: (2020-07-01) -
Baseline [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT before [<sup>177</sup>Lu]Lu-PSMA-617 Radioligand Therapy: Value of PSMA-Uptake Thresholds in Predicting Targetable Lesions
by: Daniel Groener, et al.
Published: (2023-01-01) -
Impact of [<sup>177</sup>Lu]Lu-PSMA-617 Radioligand Therapy on Reference Organ Uptake Assessed by [<sup>68</sup>Ga]Ga-PSMA-11-PET/CT
by: Daniel Groener, et al.
Published: (2023-07-01) -
Primary Staging of Prostate Cancer Patients with [<sup>18</sup>F]PSMA-1007 PET/CT Compared with [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT
by: Manuela A. Hoffmann, et al.
Published: (2022-08-01)